ArticleThe breast journal2026

Development and Validation of a Cuproptosis-Based Risk Score Model for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer: A Transcriptomic Analysis.

Lihai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.